Global Medication Adherence Market

Medication Adherence Market Size, Share, Growth Analysis, By End User(Pharmaceutical, Hospitals, Pharmacies, Healthcare providers), By Type(Hardware and Software), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35F2015 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 62 | Figures: 77

Medication Adherence Market News

  • In March 2023, Cardinal Health, a global pharmacy player, announced a new technology-based software for improving drug adherence among patients. The software uses artificial intelligence to track patient medication intake and provide personalized reminders and support.
  • In February 2023, A company called Welldoc launched a new medication adherence program that uses a combination of text messages, phone calls, and in-person visits to help patients stay on track with their medications.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Medication Adherence Market size was valued at USD 3.22 Billion in 2023 and is poised to grow from USD 3.71 Billion in 2024 to USD 11.43 Billion by 2032, growing at a CAGR of 15.1% during the forecast period (2025-2032).

The global medication adherence market is a rapidly growing market driven by the increasing focus on patient-centric healthcare, rising prevalence of chronic diseases, and advancements in technology. Key players in the market are implementing strategies such as mergers and acquisitions, partnerships, and product launches to strengthen their market position and expand their product portfolios. 'Omnicell, Inc. (United States)', 'Koninklijke Philips N.V. (Netherlands)', 'Medtronic plc (Ireland)', 'McKesson Corporation (United States)', 'Cerner Corporation (United States)', 'Becton, Dickinson and Company (United States)', 'Johnson & Johnson Services, Inc. (United States)', 'Novartis International AG (Switzerland)', 'Siemens Healthineers AG (Germany)', 'AdhereTech Inc. (United States)', 'SMRxT Inc. (United States)', 'Pillsy Inc. (United States)', 'TruMed Systems Inc. (United States)', 'Proteus Digital Health (United States)', 'West Pharmaceutical Services, Inc. (United States)', 'DrFirst, Inc. (United States)', 'Talyst LLC (United States)', 'Talis Clinical, LLC (United States)', '3M Company (United States)', 'GlobalMed Technologies (United States)', 'Hero Digital Therapeutics (United States)', 'ResMed Inc. (United States)'

The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, respiratory disorders, and cancer necessitates long-term medication adherence. This drives the demand for medication adherence solutions to optimize treatment outcomes and improve patient health.

The rise of telehealth and remote patient monitoring has facilitated medication adherence. Healthcare providers can remotely monitor patients' medication adherence and provide timely interventions or reminders. This trend has gained momentum during the COVID-19 pandemic, where virtual healthcare delivery became crucial.

North America holds the largest market share. This can be attributed to several factors such as the presence of well-established healthcare infrastructure, high healthcare expenditure, and strong adoption of advanced healthcare technologies. Additionally, government initiatives and favorable reimbursement policies further support market growth in North America. The region is also home to major market players, contributing to its dominance in the global market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Medication Adherence Market

Report ID: SQMIG35F2015

$5,300
BUY NOW GET FREE SAMPLE